Endocrine tumors of the duodenum. A study of 55 cases relative to clinicopathological features and hormone content

Hepato-Gastroenterology

Volumn 51, Issue 59, 2004, Pages 1367-1371

  Heymann, M F ^a,d   Hamy, A ^a   Triau, S ^a   Miraille E ^a   Toquet, C ^a   Chomarat, H ^b   Cohen, C ^c   Maitre, F ^c   Le Bodic, M F ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Histopathology Institute   (France)

^c Rheumatology Orléans Hospital   (France)

^d Service d'Anatomie Pathologique   (France)

Author keywords

Duodenal endocrine tumor; Immunohistochemistry; Prognosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DUODENUM TUMOR; ENDOCRINE TUMOR; FEMALE; FOLLOW UP; GASTRIN CELL; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATHOGENESIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SOMATOSTATIN CELL; SURVIVAL RATE; TUMOR CELL; ZOLLINGER ELLISON SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DUODENAL NEOPLASMS; DUODENUM; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NEOPLASM STAGING; PANCREATICODUODENECTOMY; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; ZOLLINGER-ELLISON SYNDROME;

EID: 3342918372     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Greennberg RS, Baumgartner DA, Klark WS: Pronostic factors for gastrointestinal and bronchopulmonary carcinoid tumors. Cancer 1987; 60:2476-2483.
2. Moertel CG: An odyssey in the land of small tumors. J Clin Oncol 1987; 5:1503-1522.
3. Phan GQ, Yeo CJ, Hruban RH, et al: Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 1998; 2:472-482.
4. Burke AP, Federspiel BH, Sobin LH, et al: Carcinoids of the duodenum. A histologic and immunohistochemical study of 65 tumors. Am J Surg Pathol 1989; 13:828-837.
5. Burke AP, Sobin LH, Federspiel BH, et al: Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Arch Pathol Lab Med 1990; 114:700-704.
6. Capella C, Riva C, Rindi G, et al: Endocrine tumors of the duodenum and upper jejunum. A study of 33 cases with clinico-pathological characteristics and hormone content. Hepatogastroenterology 1990; 37:247-252.
7. Whengrower D, Fich A: Primary duodenal carcinoid. Am J Gastroenterol 1987; 82:1069-1070.
8. Blaser A, Vajda P, Rosset P: Duodenal somatostatinomas associated with Von Recklinghausen disease. Schweiz Med Wochenschr 1998; 128:1984-1987.
9. Cantor AM, Rigby CC, Beck PR, et al: Neurofibromatosis, pheochromocytoma, and somatostatinoma. B med J 1982; 28:1618-1619.
10. Dayal Y, Tallberg K, Nunnemacher G, et al: Duodenal carcinoids in patients with and without neurofibromatosis. A comparative study. Am J Surg Pathol 1986; 10:348-357.
11. Griffiths DFR, Jasani B, Newman GR, et al: Glandular duodenal carcinoid - a somatostatin rich tumour with neuroendocrine associations. J Clin Pathol 1984; 37:163-169.
12. Hough DR, Chan A, Davidson H: Von Recklinghausen's disease associated with gastrointestinal carcinoid tumors. Cancer 1983; 51:2206-2208.
13. Marcial MA, Pinkus GS, Skarin A, et al: Ampullary somatostatinoma: psammomatous variant of gastrointestinal carcinoid tumor - an immunohistochemical and ultrastructural study. Report of a case and review of the literature. Am J Clin Pathol 1983; 80:755-761.
14. Posalaky Z, Mulholland M, Kasperson E, et al: Duodenal carcinoid in neurofibromatosis: a calcitonin- and amyloid-containing tumor. World J Surg 1987; 11:120-124.
15. Stamm B, Hedinger E, Saremaslani P: Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics polypeptides content and relation to MENI syndrome and Von Recklinghausen's disease neurofibromatosis. Virchows Arch (Pathol Anat) 1986; 408:475-489.
16. Wheeler MH, Curley IR, Williams ED, Path FRC: The association of neurofibromatosis pheochromocytoma and somatostatin-rich duodenal carcinoid tumor. Surgery 1986; 100:1163-1168.
17. Pipeleers-Marichal M, Donow C, Heitz PU, et al: Pathologic aspects of gastrinomas in patients with Zollinger-Ellisson syndrome with and without Multiple Endocrine Neoplasia type I. World J Surg 1993; 17:481-488.
18. Guesdon JL, Ternynck T, Auramea S: The use of avidin-biotin interactions in immunoenzymatic techniques. Histochem Cytochem 1970; 27:1131-1139.
19. Hsu SM, Raine L, Fanger H: Use of avidin-biotin peroxidase techniques a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-580.
20. Solcia E, Kloppel G, Sobin IH: Histological typing of endocrine tumours. World Health Organisation International Histological Classification Tumours, Second edition. Heidelberg, Springer, 2000.
21. Capella C, Heitz PU, Hoffler H, et al: Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Archiv 1995; 425:547-560.
22. Stommer PE, Stolte M, Seiffert E: Somatostatinoma of Vater's papilla and of minor papilla. Cancer 1987; 60:232-235.
23. Makhlouf HR, Burke AP, Sobin LH: Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer 1999; 85:1241-1249.
24. Krejs GJ, Orci L, Conlon JM, et al: Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med 1979; 301:285-292.
25. Vinick AL, Stroedel WE, Eckhauser FE, Moattari AR, Lloyd R: Somatostatinomas, Ppomas, Neurotensinomas. Semin Oncol 1987; 14:263-281.